WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
A federal judge in Delaware has thrown out two key defenses Moderna (MRNA) had been claiming in its ongoing patent litigation with Arbutus Biopharma (ABUS) regarding its mRNA COVID-19 vaccine. Judge ...
Claims center on patented mRNA architecture enabling dose reduction without loss of immunogenicity, framing next-generation formulation choices as core platform IP rather than product-specific tweaks.
Matthew Herper covers medical innovation — both its promise and its perils. Well, that didn’t take long. It took all of one week to go from an announcement that the Food and Drug Administration was ...
Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer (PFE) and BioNTech (BNTX), marking the latest such case among ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The compromise clears a path for ...
The FDA will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of-its-kind shot. Moderna announced the ...
The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval. The refusal was revealed last week in a sharply worded press release from ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results